Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Nanoform Finland Oyj (NANOFH.HE)
EUR0.83
+0.05 (+6.03%)
FI HEL Healthcare Biotechnology
Address
Cultivator II 790
Helsinki, FI
Helsinki, FI
CEO
Edward Olof Haeggstrom
Website
nanoform.com
IPO
2020-06-04
ISIN FI4000330972
Description
Helsinki, Finland-based Nanoform Finland Oyj provides advanced nanotechnology and drug particle engineering solutions for the pharmaceutical sector across Europe and the United States. The company specializes in the production of nanoparticles, utilizing its exclusive "controlled expansion of supercritical solutions" technology, which aids its clients in their development processes. Nanoform was established in 2008.
Market Cap & Enterprise Value
Merger & Acquisition History
No mergers or acquisitions recorded for this company.
Technical Outlook
Loading outlook…
Loading forecast...
Signal Summary
Loading…
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Each column is computed on that timeframe's candles (1D = daily, 1W ≈ weekly, 1M ≈ monthly), not on the same last day. ▲ bullish · ▼ bearish · — neutral. The Net row counts signals per column; hover any cell (or the indicator name) to see the exact rule behind it.
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
Indicative levels generated algorithmically. Not financial advice.
Risk Profile
Loading risk profile…
Price Chart
EUR0.83
+0.05 (+6.03%)
Loading historical data…
Volume Profile
Loading…
Liquidity & share structure
Average Volume
273.8K
Beta
0.75
Float Shares
57.75M
Free Float %
67.4%
Price Performance
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| +3.19% | +18.04% | +108.05% | +39.54% | +10.83% | -12.37% | +15.02% | -53.00% | -84.52% | -79.52% | -79.52% |
Rolling Volatility
Loading…
Drawdown
Loading…
Relative Strength
Loading…
Monthly Returns Heatmap
From
To
Loading…
Annual Monthly Returns
Loading…
Daily Returns Distribution
Loading histogram data…
Revenue flow
Revenue by geography
Revenue by segment
From
To
Revenue composition
From
To
By product
By geography
Financial Statements
Select metrics from the tables below to build your comparison.
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
Price Targets & DCF
Current price
0.83
Ratings Trend (MoM)
100% Bullish
| Rating | 2026-05 | Change |
|---|---|---|
| Strong Buy | 0 | 0 |
| Buy | 2 | 0 |
| Hold | 0 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
Quality scores
Altman Z-Score
0.58
Distress
Piotroski F-Score
2 / 9
Weak
MOAT Score
0 / 10
No MOAT
Composite Rating
C
Overall Score
2 / 5
Medium
DCF Score
1 / 5
Low
ROE Score
1 / 5
Low
ROA Score
1 / 5
Low
D/E Score
3 / 5
Medium
P/E Score
1 / 5
Low
P/Book Score
4 / 5
High
Operational MOAT
✗ Below peers
-
Revenue growth Biotechnology: +1.6%+27.7% ★ Q1'26: +45.4% (vs Q1'25)
-
EPS growth Biotechnology: +29.7%+25.0% Q1'26: +33.3% (vs Q1'25)
-
FCF margin FCF growth · Biotechnology: +16.2%-610.8% Q1'26: -294.4% (vs Q1'25)
-
EBIT margin Biotechnology: +0.0%-627.6% Q1'26: -307.6% (vs Q1'25)
-
ROIC Biotechnology: -16.1%-77.1% Q1'26: -64.6% (vs Q1'25)
-
Share dilution Biotechnology: -3.4%+2.3% ★ Q1'26: -4.1% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Biotechnology: 0.16×-0.53× Q1'26: -0.40× (vs Q1'25)
Valuation Multiples
From
To
Consensus Estimates
| Metric |
Dec 2020 actual |
Dec 2021 actual |
Dec 2022 actual |
Dec 2023 actual |
Dec 2024 actual |
Dec 2025 actual |
Dec 2026 2 Rev. Ana. 2 EPS Ana. |
Dec 2027 2 Rev. Ana. 2 EPS Ana. |
Dec 2028 2 Rev. Ana. 2 EPS Ana. |
Dec 2029 1 Rev. Ana. 1 EPS Ana. |
Dec 2030 1 Rev. Ana. 1 EPS Ana. |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue |
686.7K
est: 700.0K (-1.9%)
|
1.95M
est: 2.05M (-4.7%)
|
3.49M
est: 3.75M (-7.0%)
|
2.57M
est: 2.30M (+11.8%)
|
2.78M
est: 3.40M (-18.4%)
|
3.55M
est: 3.15M (+12.7%)
|
5.16M
4.26M – 6.06M
+64.0% YoY
|
8.52M
7.13M – 9.91M
+65.1% YoY
|
20.27M
16.88M – 23.66M
+138.0% YoY
|
34.74M
28.93M – 40.54M
+71.3% YoY
|
52.57M
43.78M – 61.37M
+51.4% YoY
|
| EBITDA |
-17.93M
est: -700.0K (-2,462.0%)
|
-17.19M
est: -2.05M (-738.6%)
|
-19.25M
est: -3.75M (-413.4%)
|
-17.85M
est: -2.30M (-677.5%)
|
-20.14M
est: -3.40M (-491.7%)
|
-19.01M
est: -3.15M (-504.2%)
|
-5.16M
-6.06M – -4.26M
-64.0% YoY
|
-8.52M
-9.91M – -7.13M
-65.1% YoY
|
-20.27M
-23.66M – -16.88M
-138.0% YoY
|
-34.74M
-40.54M – -28.93M
-71.3% YoY
|
-52.57M
-61.37M – -43.78M
-51.4% YoY
|
| EBIT |
-19.21M
est: -700.0K (-2,644.5%)
|
-19.15M
est: -2.05M (-834.2%)
|
-21.64M
est: -3.75M (-477.0%)
|
-20.73M
est: -2.30M (-802.9%)
|
-23.36M
est: -3.40M (-586.3%)
|
-22.25M
est: -3.15M (-607.2%)
|
-5.16M
-6.06M – -4.26M
-64.0% YoY
|
-8.52M
-9.91M – -7.13M
-65.1% YoY
|
-20.27M
-23.66M – -16.88M
-138.0% YoY
|
-34.74M
-40.54M – -28.93M
-71.3% YoY
|
-52.57M
-61.37M – -43.78M
-51.4% YoY
|
| Net Income |
-19.44M
est: -29.16M (+33.3%)
|
-19.69M
est: -23.74M (+17.1%)
|
-22.07M
est: -24.57M (+10.2%)
|
-20.76M
est: -21.67M (+4.2%)
|
-23.43M
est: -22.54M (-3.9%)
|
-17.90M
est: -21.31M (+16.0%)
|
-12.22M
-12.64M – -11.79M
+42.7% YoY
|
-9.38M
-10.50M – -8.25M
+23.3% YoY
|
-1.70M
-2.13M – -1.28M
+81.8% YoY
|
12.30M
9.62M – 14.97M
+821.5% YoY
|
49.43M
38.68M – 60.18M
+301.9% YoY
|
| SGA |
3.31M
est: 1.10M (+201.0%)
|
1.74M
est: 3.22M (-46.0%)
|
2.18M
est: 5.89M (-63.0%)
|
1.89M
est: 1.65M (+14.5%)
|
2.18M
est: 2.45M (-11.1%)
|
2.00M
est: 2.27M (-11.7%)
|
3.72M
3.07M – 4.37M
+64.0% YoY
|
6.14M
5.14M – 7.14M
+65.1% YoY
|
14.60M
12.16M – 17.05M
+138.0% YoY
|
25.02M
20.84M – 29.21M
+71.3% YoY
|
37.87M
31.54M – 44.21M
+51.4% YoY
|
| EPS |
-0.35
est: -0.35 (+0.0%)
|
-0.29
est: -0.29 (-1.8%)
|
-0.29
est: -0.30 (+1.7%)
|
-0.26
est: -0.28 (+5.5%)
|
-0.28
est: -0.27 (-5.0%)
|
-0.21
est: -0.25 (+16.0%)
|
-0.14
-0.15 – -0.14
+42.7% YoY
|
-0.11
-0.12 – -0.10
+23.3% YoY
|
-0.02
-0.03 – -0.02
+81.8% YoY
|
0.14
0.11 – 0.18
+821.5% YoY
|
0.58
0.45 – 0.71
+301.9% YoY
|
Historical Ratings (3M)
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-29 | C | 2/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 | 4/5 |
| 2026-05-28 | C | 2/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 | 4/5 |
| 2026-05-27 | C | 2/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 | 4/5 |
| 2026-05-26 | C | 2/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 | 4/5 |
| 2026-05-25 | C | 2/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 | 4/5 |
| 2026-05-22 | C | 2/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 | 4/5 |
| 2026-05-21 | C | 2/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 | 4/5 |
| 2026-05-20 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 3/5 |
| 2026-05-19 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 3/5 |
| 2026-05-18 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 3/5 |
| 2026-05-15 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 3/5 |
| 2026-05-13 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 3/5 |
| 2026-05-12 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 3/5 |
| 2026-05-11 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 3/5 |
| 2026-05-08 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 3/5 |
| 2026-05-07 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 3/5 |
| 2026-05-06 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 3/5 |
| 2026-05-05 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 3/5 |
| 2026-05-04 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 3/5 |
| 2026-04-30 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 3/5 |
| 2026-04-29 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 3/5 |
| 2026-04-28 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 3/5 |
| 2026-04-27 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 3/5 |
| 2026-04-24 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 3/5 |
| 2026-04-23 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 3/5 |
| 2026-04-22 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 3/5 |
| 2026-04-21 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 3/5 |
| 2026-04-20 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 3/5 |
| 2026-04-17 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 3/5 |
| 2026-04-16 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 3/5 |
Owner Earnings
Owner's Earnings (history)
From
To
Owner alignment
Owner's Earnings TTM
-9.76M
OE per share TTM
-0.12
Owner's Yield
-11.06%
Maintenance CapEx ratio
—
Maint CapEx / Avg PPE
920.0%
Ownership Overview
Ownership breakdown
Ownership breakdown not available.
At a glance
Institutional holders
—
Total invested
—
Insider transactions (90d)
0
Beneficial owners (>5%)
0
Beneficial owners (>5%)
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional ownership trend
Institutional history not available.
Top institutional holders
Top holders not available.
ETF Ownership
Top ETFs holding this stock
This company is not held by any ETF in our universe.
Insider Activity
Insider Activity — Latest Quarter
No insider activity available.
Insider buys vs sells (history)
Insider history not available.
Recent insider transactions
No recent insider transactions.
Executive team
Top executives
EBIT / Employee
-1.2K
Shares Outstanding
85.67M
Executive compensation
Executive compensation (annual)
Executive compensation not available.
CEO compensation breakdown
No CEO compensation history available.
Proxy statements
Proxy statements (DEF 14A)
No proxy statements available for this company yet.
Recent SEC filings
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Albert Alexander Haeggstrom | Chief Financial Officer & Director | 60.0K | male |
| Antonio Da Silva | Chief of Business Operations | — | male |
| Christian Jones | Chief Commercial Officer | — | male |
| David Rowe | Head of Manufacturing | — | — |
| Edward Olof Haeggstrom | Co-Founder & Chief Executive Officer | — | — |
| Henri von Haartman | Director of Investor Relations | — | male |
| Jamie Unwin | Vice President of Strategic Insight | — | — |
| Johanna Kause | Chief Quality Officer | — | female |
| Peter Hanninen | General Counsel & Chief Development Officer | — | male |
ESG Score History
No data available for this company.
Senate Trading Activity
No Senate trading activity found for this company.
House Trading Activity
No House trading activity found for this company.
Market share among peers
Peer comparison — filtered group (TTM)
Your opinion
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for NANOFH.HE
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
